Cargando…
Doxorubicin and vinorelbine act independently via p53 expression and p38 activation respectively in breast cancer cell lines
In the treatment of breast cancer, combination chemotherapy is used to overcome drug resistance. Combining doxorubicin and vinorelbine in the treatment of patients with metastatic breast cancer has shown high response rates; even single-agent vinorelbine in patients previously exposed to anthracycli...
Autores principales: | , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2747573/ https://www.ncbi.nlm.nih.gov/pubmed/12698197 http://dx.doi.org/10.1038/sj.bjc.6600898 |